We hypothesize that GLO-1 overexpression can decrease diabetes-induced glycation, oxidative stress, and inflammation in the heart and thereby, prevent fibrosis and eventually systolic cardiac dysfunction. Here, GLO1 is linked to diabetes mellitus.